[A COMPARISON OF TWO APPROACHES FOR INTRAOPERATIVE LEVOSIMENDAN ADMINISTRATION IN CARDIAC SURGICAL PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION.]
V V PasyugaS I BelovE S YusupovaR R AdzhigalievS A BerezhnoyO S PanovD G TarasovA G YavorovskyPublished in: Anesteziologiia i reanimatologiia (2018)
Based on these data it can be assumed that the use of prolonged infusion of levosimendan in a dosage of 12.5 mg is preferable to a single bolus 24 μg/kg.
Keyphrases
- cardiac surgery
- acute kidney injury
- electronic health record
- left ventricular
- pulmonary artery
- pulmonary hypertension
- low dose
- mitral valve
- oxidative stress
- early onset
- big data
- patients undergoing
- heart failure
- coronary artery
- congenital heart disease
- machine learning
- artificial intelligence
- pulmonary arterial hypertension